GB2073019A - Oral compositions containing tranexamic acid - Google Patents
Oral compositions containing tranexamic acid Download PDFInfo
- Publication number
- GB2073019A GB2073019A GB8110546A GB8110546A GB2073019A GB 2073019 A GB2073019 A GB 2073019A GB 8110546 A GB8110546 A GB 8110546A GB 8110546 A GB8110546 A GB 8110546A GB 2073019 A GB2073019 A GB 2073019A
- Authority
- GB
- United Kingdom
- Prior art keywords
- tranexamic acid
- weight
- carvone
- menthol
- blended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
An oral composition containing tranexamic acid having improved palatability in which carvone is blended in an amount of 0.1 to 5% by weight and I-methanol may preferably be blended in an amount of 0.03 to 10% by weight. The composition may preferably contain a mixed humectant of sorbitol and glycerin at a weight ratio of 1:9 to 6:4 and a binder, at least 60% by weight of the binder being an alkali metal salt of carboxymethyl cellulose.
Description
SPECIFICATION
Oral composition
This invention relates to transexamic acid-containing oral compositions having a pleasant feel in use.
Tranexamic acid is a well-known anti-inflammatory and hemostyptic agent. It is proposed in
Japanese Patent Publication No. 49-39818 to incorporate tranexamic acid into oral compositions such as dentifrices because tranexamic acid is effective for periodontosis prophylaxis.
However, as tranexamic acid inherently tastes bitter, oral compositions containing it are bitter and rough to the palate, giving an unpleasant feel when orally applied in practice.
An additional disadvantage of such tranexamic acid-containing oral compositions is that they are unstable and tend to discolor upon aging. It was proposed to add cyclodextrin to tranexamic acidcontaining oral compositions to prevent discoloration. In general, known techniques for preventing the discoloration of oral compositions such as dentifrices include the addition of a chelating agent or a polycarboxylic acid derivative. However, these approaches have been unsuccessful. When cyclodextrin is blended in an oral composition, a flavor coexisting in the composition is chemically included by cyclodextrin to reduce flavoring effect, and as a result, this composition fails to give a refreshing feel to the mouth when applied thereto. Another problem is a reduction of the net amount of active antiplasmin tranexamic acid due to-chemical inclusion of tranexamic acid by cyclodextrin.Further, when a chelating agent or a polycarboxylic acid derivative is blended, precautions should be taken so as to minimize the adsorption of calcium ions by these compounds acting on teeth.
A primary object of the present invention is to provide a tranexamic acid-containing oral composition which has a soft taste and a favorable feel on use while its bitterness is minimized.
According to the present invention, there is provided a tranexamic acid-containing oral composition comprising 0.1 to 5% by weight of the composition of carvone.
By blending carvone in a tranexamic acid-containing oral composition in the above specified amounts, the feel of the composition on use is improved to an acceptable level. The presence of carvone allows tranexamic acid to be effectively incorporated into oral compositions such as dentifrices as an active ingredient.
In a preferred embodiment of the present invention, I-menthol is used in combination with carvone. Particularly, when carvone and I-menthol are blended at a weight ratio of from 1:9 to 9:1, more preferably from 3:7 to 7:3, not only the composition has an enhanced refreshing action and a further improved feel in use, but also the aging discoloration is substantially minimized. The resulting tranexamic acid-containing oral composition is stable, refreshing and favorable.
In another preferred embodiment of the present invention, the tranexamic acid-containing oral composition further comprises a mixed humectant consisting of sorbitol and glycerine at a relative ratio by weight of 1:9 to 6:4 and a binder of which at least 60% by weight is an alkali metal salt of carboxymethyl cellulose. By blending the above mixed humectant and the binder containing at least 60% by weight of an alkali metal salt of carboxymethyl cellulose on the basis of the weight of the binder, the tranexamic acid-containing oral compositions are prevented from discoloring and become more stable. In addition, the action of tranexamic acid or the function of tranexamic acid in tranexamic acid-containing oral compositions is fully exerted as tranexamic acid and flavors are free from being chemically included.
The above and other objects, features and advantages of the present invention will become more apparent and understandable from the following descriptions.
The oral composition of the present invention is contemplated to include dentifrices such as toothpastes, toothpowders and liquid dentifrices, liquid oral refreshers such as mouthwashes, solid oral refreshers such as troches, chewing gums, and oral pastes as long as they contain an effective amount of tranexamic acid. According to the first aspect of the present invention, carvone is blended in such an oral composition containing tranexamic acid. Carvone should be blended in an amount of 0.1 to 5%, preferably 0.3 to 3% by weight of the composition.The use of carvone contributes to an improvement in the feel of the composition by reducing its bitterness due to tranexamic acid and imparting a soft taste to it, although the use of conventional flavors such as I-menthol, eucalyptus oil, strawberry flavor, sage oil, rosemary oil alone or in admixture results in no reduction of the bitterness attributable to tranexamic acid. Less than 0.1% amounts of carvone blended will not fully overcome bitterness and rough taste.
Blending more than 5% of carvone is undesired because the pungency of carvone itself becomes sensible. Accordingly, only 0.1 to 5%, preferably 0.3 to 3% of carvone provides tranexamic acidcontaining oral compositions with an acceptable soft taste free of bitterness and pungency.
As iong as carvone is blended in the above-specified range, any other flavors may also be blended in addition to carvone, including I-menthol, anethole, eugenol, linalool, cineole, limonene, and cinnamic aldehyde alone or in admixture.
Particularly, it is preferred to blend I-menthol in combination with carvone because the combined use of these flavors can not only provide the tranexamic acid-containing compositions with an optimum degree of coolness and even improve its feel on use, particularly in the case of dentifrices, but also improve the stability of the compositions and prevent them from discoloring upon long-term aging. It is preferred from points of view of feel on use and stability that carvone and I-menthol are present at a relative weight ratio of from 1:9 to 9:1. The best feel on use including minimum bitterness, soft taste and refreshment as well as the best aging stability result at a relative ratio of carvone to I-menthol of 3:7 to 7:3. If I-menthol is present, the oral composition should preferably contain 0.03 to 10% by weight of the composition of I-menthol.Less than 0.03% amount of I-menthol blended is too small to form a refreshing stable composition. On the other hand, compositions will become too irritant to give a good feel to use when the amount of I-menthol blended exceeds 10%.
Carvone and I-menthol may be blended into an oral composition in an isolated or synthetic form while essential oils containing carvone or I-menthol may be used, for example, spearmint oil (containing carvone) and peppermint oil (containing I-menthol).
The amount of tranexamic acid blended is not particularly limited in the present invention, but is generally in the range of 0.01 too by weight of the composition. In addition to tranexamic acid, the oral composition of this invention may further include other additional active ingredients, for example, enzymes such as amylase, protease, mutanase, lysozyme, lytic enzyme, etc., fluorine compounds such as alkali metal monofluorophosphates (e.g., sodium monofluorophosphate, dipotassium monofluorophosphate, etc.) and metal fluorides (e.g., sodium flouride, stannous flouride, etc.), stannous compounds, chlorhexidine salts, E-aminocaproic acid, aluminum chlorohydroxyallantoinate, dihydrocholesterol, glycyrrhetinates, glycerophosphate, sodium chloride, water-soluble inorganic phosphates (e.g., potassium and sodium salts of orthophosphoric acid, pyrophosphoric acid and polyphosphoric acid) and the like alone or in admixture.
The oral composition of this invention may further include other well-known ingredients depending on a particular type of the composition. Differently stated, the oral composition of this invention may be formulated into any desired form of dentifrices, liquid and solid oral refreshers and oral pastes by a conventional preparation method using suitably selected ingredients.
When the oral composition of the present invention forms a dentifrice composition, it may contain generally 10 to 90% by weight of an abrasive, particularly 20-to 60% by weight of an abrasive in the case of toothpastes. The abrasive may be selected from dicalcium phosphate dihydrate and anhydride, calcium carbonate, calcium pyrophosphate, calcium sulfate, silica, hydrous silicic acid, alumina, aluminum silicate, aluminum hydroxide, insoluble sodium metaphosphate, magnesium tertiary phosphate, magnesium carbonate and synthetic resins, and mixtures thereof.
A humectant may also be blended generally in an amount of 585% by weight, including sorbitol, glycerine, ethylene glycol, propylene glycol, 1 ,3-butylene glycol, polyethylene glycol, xylitol, maltitol, lactitol, etc. and mixtures thereof.
In preparing dentifrice compositions, a binder may be blended generally in an amount of 0.35% by weight, including cellulose derivatives such as sodium carboxymethyl cellulose and hydroxyethyl cellulose, carrageenan, alkali metal alginates such as sodium alginate, gums such as veegum and xanthan gum, synthetic binding agents such as polyvinyl alcohol, inorganic binding agents such as silica gel, aluminum silicate gel, etc. and mixtures thereof.
It is preferred in the present invention that the oral composition contains a mixed humectant consisting of sorbitol and glycerine at a relative weight ratio of from 1:9 to 6:4, and a binder, at least 60% by weight of the binder being an alkali metal salt of carboxymethyl cellulose such as sodium carboxymethyl cellulose. The aging stability of tranexamic acid-containing oral compositions can be remarkably improved by blending both the humectant and binder so as to meet the above requirements.
If the ratio of sorbitol to glycerine is out of the above-defined range, then tranexamic acid-containing oral compositions are likely to discolor upon aging. Similar discoloration occurs and stability decreases if the amount of the alkali metal salt of carboxymethyl cellulose is less than 60% by weight of the total weight of the binder. In this preferred embodiment, the oral composition may advantageously contain 5 to 85% by weight of the composition of the mixed humectant consisting of sorbitol and glycerine, more particularly, 10 to 70% of the mixed humectant in the case of ordinary toothpastes, 50 to 85% in the
case of transparent toothpastes, and 5 to 1 5% in the case of toothpowders.
It is to be noted that propylene glycol may preferably be added as a binder dispersing agent. In such a case, propylene glycol may be blended in an amount of 5% or less, especially 1 to 5% by weight of the composition. Larger amounts of propylene glycol cause tranexamic acid-containing oral compositions to discolor upon aging and impart to them an undesired scorching taste. On the other hand, the binder cannot be effectively dispersed using less than 1% by weight of propylene glycol.
In oral compositions, also included are anionic surfactants such as water-soluble salts of higher alkyl sulfates having 8 to 1 8 carbon atoms in the alkyl group (e.g., sodium lauryl sulfate and sodium myristyl sulfate), water-soluble salts of sulfonated monoglycerides of higher fatty acids having 10 to 1 8 carbon atoms in the fatty acid group (e.g., sodium lauryl monoglyceride sulfonate and sodium coconut monoglyceride sulfonate), a-olefine sulfonates, salts of amides of higher fatty acids having 12 to 1 6
carbon atoms in tba fatty acid group with lower aliphatic amino acids (e.g. sodium-N-methyl-N-palmitoyl tauride, sodium N-lauroyl sarcosinate, sodium N-acyl amino acid and sodium N-lauroyl-p-alanine), soaps, etc.; nonionic surfactants such as alkoyl diethanol amides (e.g. lauroyl diethanol amide), stearyl
monoglyceride, sucrose fatty acid esters having 12 to 18 carbon atoms in the fatty acid group
(e.g. sucrose monolaurate and dilaurate), lactose fatty acid esters, lactitol fatty acid esters, maltitol fatty acid esters, condensates of sorbitan monostearate with approximately 60 moles of ethylene oxide, condensates of ethylene oxide with propylene oxide condensates of propylene glycol and their derivatives (e.g. polyoxyethylene polyoxypropylene monolauryl ester), etc; amphoteric surfactants such as those of betaine and amine acid types, etc..
alone or in admixture in an amount of 0.57% by weight; a sweetener such as sodium saccharine, steviodide, neohesperidin dihydrocalcone, thaumatin, glycyrrhizin, perillartine, p-methoxycinnamic aldehyde, etc.; a preservative such as p-hydroxy methyl benzoic acid, p-hydroxy-butyl benzoic acid, etc.;, gelatin, peptone and other ingredients. It is to be noted that the para-substituted benzoic acid preservative should be blended in amounts of 0.3% by weight or less because compositions become too irritant when the amount exceeds 0.3%.
For example, toothpastes may be prepared by kneading the desired ingredients selected from the foregoing ingredients with a proper amount of water or other solvents.
The toothpastes may generally have a pH of 4.5 to 10, preferably 6 to 8.5.
Other types of oral compositions may be prepared in accordance with conventional formulations and methods using a well-known base material.
The thus prepared composition may be ready for use only after it is packed in a suitable container, for example, aluminum tubes, laminate tubes having an aluminum foil laminated with a plastic lamina on either side, plastic tubes, bottles, aerosol containers or the like.
The following examples are illustrative of this invention and are not to be construed to limit the scope of the invention. All percents are by weight.
Example 1
Solid mouth refresher compositions having the formulation shown below were prepared while blending the flavors shown in Table 1. Using a panel of specialized members, a sensory test was carried out to determine the feel of these compositions on actual use. The results are shown in the right column of Table 1.
Formulation
Lactose 11.5
Starch 30
Orris powder 5
Tranexamic acid 0.5
Flavor shown in Table 1 (see Table 1)
Gum arabic solution Balance
100.0
TABLE 1
Sample Amount No. Flavor (%) Bitterness I Carvone 0.05 X 2 .. 0.1 0 3 1, 1 0 4 IS 3 0 5 S, 5 0 6 II 7 V 7 I-menthol 3 X 8 Eucalyptus oil 3 X 9 Strawberry flavor 3 X 10 Sage oil 3 X 11 Rosemary oil 3 X 12 - - X Note 1: The criteria for evaluating bitterness are as follows.
0: not bitter
A: slightly bitter
X: bitter
V: not bitter, but pungent
Note 2: Those refreshers of the same formulation as sample Nos. 7-12, but not containing tranexamic
acid did not taste bitter.
As seen from the results of Table 1, carvone is effective for improving the feeling of tranexamic acid-containing oral compositions which otherwise taste bitter and are rough to the palate. The test proves that the shortcomings of tranexamic acid-containing oral compositions, that is, their own bitterness and lack of soft taste, are eliminated by blending 0.1 to 5% by weight of carvone therein.
Example 2
Using carvone in combination with 1-menthol in the respective amounts shown in Table 2, toothpastes having the formulation shown below were prepared. A sensory test was carried out to determine the feel (bitterness, softness of taste, and refreshing taste referred to below as refreshment) of these toothpaste on actual use. In addition, a portion of each toothpaste was aged for one month at 600C before it was determined for discoloration to evaluate its stability. The results are shown in Table 2.
Formulation
Propylene glycol 3
Sodium carboxymethyl cellulose 0.6
Carrageenan 0.4
Sorbitol 5
Glycerine 12
Sodium saccharin 0.1
Hydrated silica 3
Sodium lauryl sulfate 1.5
Dicalcium phosphate 45
Tranexamic acid 0.5
Flavors (carvone and I-menthol) (see Table 2)
Water Balance 100.0 TABLE 2
Amount of Amount of carvone 1-menthol blended blended Sofiness Stability (%) (%) Bittemess of taste Refreshment (discoloration) 1.0 0 0 0 x # 0.9 0.1 0 0 # 0 0.7 0.3 0 0 0 0 0.5 0.5 0 0 0 0 0.3 0.7 0 0 0 0 0.1 0.9 # # 0 0 0 1.0 x x 0 0 The evaluation criterion for each item is as follows.
Bitterness
0: not bitter
A: slightly bitter
X: bitter
Softness of taste
0: soft
A: moderate
X: rough
Notes to Table 2 -- continued Refreshment
0: refreshing
A: moderately refreshing
X: unrefreshing
Stability after 600 C, 1 month aging
0: no discoloration A: some discoloration
X: significant discoloration
The results of Table 2 reveals that the combined use of carvone and I-menthol at a relative weight ratio of 1:9 to 9:1, preferably at a relative weight ratio of 3:7 to 7:3, results in tranexamic acidcontaining oral compositions which are free of bitterness or rough taste and highly refreshing, and consequently, has a good feel on use as well as being highly stable as demonstrated by discolorationfree long-term aging.
An additiorial test was carried out to find that I-menthol may preferably be added in amounts of 0.03 to 1 QA to give stable oral compositions having a good feeling on use.
Example 3
Using sorbitol and glycerine in the relative weight ratios shown in Table 3, toothpastes having the formulation shown below were prepared. The toothpastes were aged for one month at 600C before they were determined for discoloration to evaluate their stability. The results are shown in Table 3.
Formulation
Propylene glycol 2.5
Humectant (sorbitol and glycerine) 16.0
Sodium carboxymethyl cellulose 0.8
Carrageenan 0.2
Dicalcium phosphate 45.0
Hydrated silica 3.0
Sodium lauryl sulfate 1.5
Sodium saccharin 0.1
Carvone 0.3
I-menthol 0.7
Tranexamic acid (see Table 3)
Water Balance
100.0
TABLE 3 Stability
Ratio of sorbitol to glycerine Amount of (ratio by weight) tranexamic acid blended (O/o) 100 to 85/15 70/30 50 /50 30/70 15/85 0/100 0 0 0 0 0 0 0 0 0.5 X X X O 0 O X Notes to Table 3
The evaluation criterion for stability (discoloration stability) is as follows.
0: no discoloration
A: some discoloration
X: significant discoloration
The results of Table 3 reveals that aging discoloration is prevented and hence, stability is improved when mixed humectants of sorbitol and glycerine at a relative weight ratio of 1:9 to 6:4 are blended in tranexamic acid-containing oral compositions.
Example 4
Toothpastes were prepared using the formulation of Example 3 except that the relative weight ratio of sorbitol to glycerine was fixed to 3:7 and the combined amount of sodium carboxymethyl cellulose (CMC) and carrageenan was 1.0%. The relative weight ratio of CMC to carrageenan was varied as shown in Table 4. The aging stability of the toothpastes was determined as described in Example 3.
The results are shown in Table 4.
TABLE 4 Stability
Ratio of OMO to carrageenan Amount of (ratio by weight) tranexamic acid blended (%) 10/0 8/2 6/4 5/5 4/6 2/8 0/10 0 0 0 0 0 0 0 0 0.5 0 0 O X X X X The results of Table 4 reveals that the aging stability of tranexamic acid-containing oral compositions is improved when CMC and carrageenan are blended at a ratio of 6:4 to 10:0. It was found that similar results were obtained when carrageenan was replaced by sodium alginate.
Accordingly, the aging stability of tranexamic acid-containing oral compositions is improved when sodium carboxymethy cellulose (CMC) occupies 60% or more of the binder blended.
Example 5
Toothpastes were prepared using the formulation of Example 3 except that the relative weight ratio of sorbitol to glycerine was fixed to 3:7 and the amount of propylene glycol blended was varied as shown in Table 5. The aging stability of the toothpastes was determined as described in Example 3. The results are shown in Table 5.
TABLE 5
Stability
Amount of propylene glycol blended ( Amount of tranexamic acid blended (%) 3 5 6 0 0 0 0.5 O O X As seen from Table 5, it is preferred to blend 5% or less of propylene glycol in tranexamic acidcontaining oral composition for improving the stability thereof.
Example 6 Toothpaste
Aluminum hydroxide 50%
Hydrated silica 3%
Propylene glycol 2%
Sorbitol 3%
Glycerine 15% Sodium saccharin 0.1%
Sodium lauryl sulfate 1.5 Sodium carboxymethyl cellulose 1.0%
Tranexamic acid 0.1%
Carvone 0.3%
1-menthol 0.7%
Water Balance
100.0%
Example 7 Toothpaste
Dicalcium phosphate 50%
Propylene glycol 3%
Sorbitol 5%
Glycerine 12% Sodium saccharin 0.1 Sodium lauryl sulfate 1.0%
Sucrose monolaurate 1.0 Carrageenan 0.3%
Sodium carboxymethyl cellulose 0.7%
Sodium monofluorophosphate 0.76%
Tranexamic acid 0.05%
Carvone 0.5%
I-menthol 0.5%
Anethole 0.1%
Water Balance
100.0%
Example 8 Powder dentifrice
Calcium carbonate 70%
Sorbitol 3%
Glycerine 7%
Sodium saccharin 0.1%
Sodium lauryl sulfate 1.5%
Tranexamic acid 0.03%
Carvone 0.8%
I-menthol 0.2%
Water Balance 100.0% Example 9 Toothpaste
Silica 20%
Propylene glycol 2%
Sorbitol 20%
Glycerine 40%
Sodium saccharin 0.1%
Sodium lauryl sulfate 1.0%
Sucrose monolaurate 1.0%
Lactitol monolaurate 1.0%
Carrageenan 0.5%
Sodium carboxymethyl cellulose 0.5%
Chlorhexidine hydrochloride 0.01%
Tranexamic acid 0.5%
Carvone 0.6%
I-menthol 0.4% Eugenol 0.1% Water Balance 100.0% Example 10 Toothpaste
Calcium pyrophosphate 50%
Propylene glycol 4%
Sorbitol 9%
Glycerine 11% Stevioside 0.1%
Dipotassium glycyrrhizinate 0.05%
Lactitol monolaurate 2.0%
Carrageenan 0.2%
Sodium carboxymethyl cellulose 0.8%
Sodium alginate 0.2%
Tranexamic acid 1.0%
Carvone 0.5%
1-menthol 0.5%
Anethole 0.1%
Eugenol 0.05%
Linalool 0.05%
Cineole 0.05 Water Balance
100.0%
Example 11 Liquid dentifrice
Glycerine 35%
Propylene glycol 5%
Sodium polyacrylate 3%
Sodium lauryl sulfate 1%
Sodium saccharin 0.2%
Ethanol 3%
Carvone 1.5 1-menthol 0.5%
Tranexamic acid 3.0%
Water Balance
100.0%
Example 12 Mouthwash
Ethanol (90%) 20%
Sodium saccharin 0.3%
Polyoxyethylene-hardened castor oil 0.5%
Carvone 1.5%
I-menthol 1.5%
Anethole 0.2%
Eugenol 0.1% Linalool 0.1%
Cineole 0.1% Tranexamic acid 0.05%
Water Balance 100.0% Example 13 Troche
Gum arabic 6%
Glucose 72%
Carvone 0.4%
I-menthol 0.1% Spearmint oil 0.1%
Tranexamic acid 0.1%
Water Balance 100.0% Example 14 Chewing gum
Gum base 20%
Calcium carbonate 2%
Syrup 15% Powdered sugar 60%
Carvone 0.9%
I-menthol 1.5%
Anethole 0.1% Tranexamic acid 0.5% 100.0% Example 1 5 Oral paste
Liquid paraffin 26%
Sorbitol 5%
Glycerine 15% Cetanol 4%
Paraffin wax 6%
Microcrystalline wax 10%
Polyoxyethylene sorbitan monooleate 5%
Carvone 0.5%
I-menthol 0.5%
Tranexamic acid 0.1%
Water Balance 100.0% Example 1 6 Solid mouth refresher
Lactose 11% Starch 40%
Orris powder 5%
Gum arabic solution 40%
Carvone 3%
Tranexamic acid 1% 100.0% The oral compositions of Examples 6 to 1 6 were found to give a good feel on use and be stable even after long-term aging.
Claims (9)
1. An oral composition containing tranexamic acid, wherein carvone is present in an amount of 0.1 to 5% by weight of the composition.
2. An oral composition according to claim 1 wherein tranexamic acid is present in an amount of 0.01 to 5% by weight of the composition.
3. An oral composition according to claim 1 or claim 2 which further contains I-menthol.
4. An oral composition according to claim 3 wherein carvone and I-menthol are blended at a weight ratio of from 1:9 to 9:1.
5. An oral composition according to claim 4 wherein carvone and I-menthol are blended at a weight ratio of from 3:7 to 7:3.
6. An oral composition according to claim 3, 4 or 5 wherein I-menthol is present in an amount of 0.03 to 10% by weight of the composition.
7. An oral composition according to any one of the preceding claims which further contains a mixed humectant of sorbitol and glycerine blended at a weight ratio of 1:9 to 6:4 and a binder, at least 60% by weight of the binder being an alkali metal salt of carboxymethyl cellulose.
8. An oral composition according to claim 7 wherein the combined amount of sorbitol and glycerine is 5 to 85% and the amount of the binder is 0.3 to 5% by weight of the composition.
9. An oral composition according to claim 7 or 8 which further contains 1 to 5% by weight of the composition of propylene glycol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4582380A JPS56158707A (en) | 1980-04-08 | 1980-04-08 | Composition for oral use |
JP4582280A JPS56142205A (en) | 1980-04-08 | 1980-04-08 | Composition for oral cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2073019A true GB2073019A (en) | 1981-10-14 |
GB2073019B GB2073019B (en) | 1984-06-20 |
Family
ID=26385905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8110546A Expired GB2073019B (en) | 1980-04-08 | 1981-04-03 | Oral compositions containing tranexamic acid |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2073019B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2474862A1 (en) * | 1980-01-31 | 1981-08-07 | Colgate Palmolive Co | PROPHYLACTIC BUCCAL COMPOSITION BASED ON TRANS-4- (AMINOMETHYL) CYCLOHEXANE-1-CARBOXYLIC ACID |
GB2122491A (en) * | 1982-06-30 | 1984-01-18 | Lion Corp | Dentifrices |
US4465662A (en) * | 1980-04-08 | 1984-08-14 | Lion Corporation | Oral compositions of tranexamic acid and carvone |
US4469673A (en) * | 1980-02-06 | 1984-09-04 | Lion Corporation | Oral composition |
WO2005011650A1 (en) * | 2003-07-31 | 2005-02-10 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US8022106B2 (en) | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
US8273795B2 (en) | 2004-03-04 | 2012-09-25 | Ferring B.V. | Tranexamic acid formulations |
US8957113B2 (en) | 2004-03-04 | 2015-02-17 | Ferring B.V. | Tranexamic acid formulations |
CN108969413A (en) * | 2017-06-05 | 2018-12-11 | 狮王株式会社 | Composition for oral cavity |
-
1981
- 1981-04-03 GB GB8110546A patent/GB2073019B/en not_active Expired
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2474862A1 (en) * | 1980-01-31 | 1981-08-07 | Colgate Palmolive Co | PROPHYLACTIC BUCCAL COMPOSITION BASED ON TRANS-4- (AMINOMETHYL) CYCLOHEXANE-1-CARBOXYLIC ACID |
US4469673A (en) * | 1980-02-06 | 1984-09-04 | Lion Corporation | Oral composition |
US4465662A (en) * | 1980-04-08 | 1984-08-14 | Lion Corporation | Oral compositions of tranexamic acid and carvone |
GB2122491A (en) * | 1982-06-30 | 1984-01-18 | Lion Corp | Dentifrices |
US4649044A (en) * | 1982-06-30 | 1987-03-10 | Lion Corporation | Oral composition |
WO2005011650A1 (en) * | 2003-07-31 | 2005-02-10 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
US8968777B2 (en) | 2003-07-31 | 2015-03-03 | Ferring B.V. | Tranexamic acid formulations with reduced adverse effects |
US8273795B2 (en) | 2004-03-04 | 2012-09-25 | Ferring B.V. | Tranexamic acid formulations |
US8022106B2 (en) | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
US8487005B2 (en) | 2004-03-04 | 2013-07-16 | Ferring B.V. | Tranexamic acid formulations |
US8791160B2 (en) | 2004-03-04 | 2014-07-29 | Ferring B.V. | Tranexamic acid formulations |
US8809394B2 (en) | 2004-03-04 | 2014-08-19 | Ferring B.V. | Tranexamic acid formulations |
US8957113B2 (en) | 2004-03-04 | 2015-02-17 | Ferring B.V. | Tranexamic acid formulations |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US9060939B2 (en) | 2004-03-04 | 2015-06-23 | Ferring B.V. | Tranexamic acid formulations |
CN108969413A (en) * | 2017-06-05 | 2018-12-11 | 狮王株式会社 | Composition for oral cavity |
Also Published As
Publication number | Publication date |
---|---|
GB2073019B (en) | 1984-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4465662A (en) | Oral compositions of tranexamic acid and carvone | |
US4469673A (en) | Oral composition | |
US4466954A (en) | Oral composition | |
US5096699A (en) | Anticalculus oral compositions | |
CA1262687A (en) | Antiplaque dentifrice having improved flavor | |
KR0169139B1 (en) | Taste preserving, mild oral hygiene compositions | |
JPH0536409B2 (en) | ||
US4774078A (en) | Stable antiplaque dentifrice based on hexetidine, zinc ion and fluoride | |
US5348733A (en) | Oral composition | |
US4547361A (en) | Stabilizing of cinnamic aldehyde-containing flavors with propylene glycol and dipropylene glycol | |
EP0348560A1 (en) | Oral composition | |
GB2073019A (en) | Oral compositions containing tranexamic acid | |
JPH01160911A (en) | Composition for oral cavity | |
US3894147A (en) | Method and composition for inhibiting calculus | |
EP0277400B1 (en) | Oral compositions | |
JPH0772124B2 (en) | Oral composition | |
JPH0211511A (en) | Composition for oral cavity | |
JPS6155892B2 (en) | ||
GB2090137A (en) | Oral composition | |
JPH0680005B2 (en) | Oral composition | |
JP2546226B2 (en) | Method for preventing rough skin of toothpaste composition containing benzoic acids | |
SG173839A1 (en) | Oral care compositions comprising tetrapotassium pyrophosphate | |
JP2854114B2 (en) | Oral composition | |
JP2610444B2 (en) | Oral composition | |
JPS6216925B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19980403 |